Ireland
--:--IST
Active, not recruiting Observational

Functional Abdominal Wall Reconstruction

NCT06928974 · tracked via the Priya Life Science Poland tracker
Phase
Observational
Started
2017-01-01
Last updated
2025-04-15

Condition(s) studied

Prune Belly Syndrome

Investigational drug(s) / intervention(s)

Bilateral Pedicled Vastus Lateralis Muscle Flaps Transposition

Bilateral Pedicled Vastus Lateralis Muscle Flaps Transposition: Bilateral Pedicled Vastus Lateralis Muscle Flaps Transposition to restore the function of underdeveloped or absent rectus abdomini muscles

Study summary

Assessement of outcomes of functional reconstruction of underdeveloped abdominal muscles with the use od pedicled Vastus Lateralis Muscle flaps.

Eligibility

Sex
ALL
Min age
—
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Patients diagnoes with Prune Belly Syndrome * severe underdevelopment of rectus abdomini muscles * patients who underwent microsurgical bipedicled vastus lateralis muscle flaps transposition * patient undery 18 y.o. Exclusion Criteria: * Patient over the age of 18 * Patients who did not agreed for proposed microsurgical reconstruction of the abdominal wall Exclusion Criteria: Patient over the age of 18 \-

Primary outcome measure(s)

  • Electromyography — followup reached 96months
    To assess the proper function of transposed muscles the electromyographic tests were used to assess the proper electroactivity of transposed vastus lateralis muscles. The measured values of amplitude (mV) and conduction velocity(ms) were analyzed.
  • Motor tests - performance of ''sit-up''-like movement — Followup reached 96 months
    Patients were asked to perform situp-like movement with legs fasetned before surgical transposition of muscles and then 12 months postoperatively. It was assessed in 0/1 manner. 0 - patient not able to do the sit-up, 1 - patient able to do the sit-up

Trial sites (1)

FacilityCityRegionStatus
Maria Sklodowska Curie Memorial National Cancer Center Gliwice Poland
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06928974 on ClinicalTrials.gov ↗ ← All trials in Poland